mlt-231

MLT-231, a potent and highly selective allosteric MALT1 inhibitor, has an IC50 of 9 nM and specifically inhibits endogenous BCL10 cleavage with an IC50 of 160 nM. It exhibits antitumor activity in an ABC-DLBCL type xenograft mouse model[1].

Melatonin-Tamoxifen Conjugate (compound 16c) 是一种抗癌药物偶联物，结合了Melatonin 和Tamoxifen，作为ERα的有效拮抗剂 (IC50=863 nM)。此偶联物在表达hMT1受体的细胞中对MLT受体具有高度亲和力 (Ki=3.1 nM)，并可促进β-arrestin (EC50=914 nM) 和ERK的激活 (EC50=98 nM)。其对MCF-7、MDA-MB-231和HT-1080等常见细胞系的IC50分别为6.8 μM、6.4 μM和1.7 μM。